5 recruiting, 4 unknown, 2 active not recruiting, 2 completed. 6 Not applicable, 2 Phase 1, 2 Phase 2, 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Recruiting 2, Unknown 2, Completed 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 2 | Active not recruiting 2 |
| Phase 4 | 2 | Recruiting 1, Unknown 1 |
Follow Neoplasm, Breast: new trials by email Literature Review of Neoplasm, Breast trials Research Report on Neoplasm, Breast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells for the Treatment of Metastatic Breast Cancer HTR2 T Cells - Breast Cancer, Tumor, Breast | Phase 1 | Recruiting | Baylor College of Medicine | 27 | 2026-08-03 | 2026-09-24 |
| Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM) Sacubitril-valsartan, Placebo - Breast Cancer, Neoplasm, Breast | Phase 4 | Recruiting | Silesian Centre for Heart Diseases | 600 | 2024-04-17 | 2025-03-14 |
| TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy - Breast Cancer, Neoplasm, Breast | Not applicable | Recruiting | Taipei City Hospital | 80 | 2024-03-13 | 2025-06-04 |
| Development, Implementation and Evaluation of an Individual Decision Aid in Swedish Cancer Screening Programs Individual decision aid (iDA) - Neoplasm, Colorectal, Neoplasm, Breast | Not applicable | Withdrawn | Karolinska Institutet | 2023-03-01 | 2026-02-11 | |
| Identifying Biomarkers for Chronic Pain After Breast Cancer Treatment. Biomarkers - Neoplasm, Breast, Carcinoma Breast | Unknown | Universiteit Antwerpen | 150 | 2022-10-04 | 2023-12-27 | |
| Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study Echocardiography - Neoplasm, Breast, Heart Failure | Recruiting | University Medical Center Groningen | 455 | 2022-09-01 | 2024-05-29 | |
| SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast) Alpelisib 150 MG Oral Tablet [Piqray], Fulvestrant - Neoplasm, Breast, Congenital, Familial and Genetic Disorders | Phase 2 | Active not recruiting | Borstkanker Onderzoek Groep | 130 | 2022-06-02 | 2026-05-22 |
| Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer Eribulin Injection [Halaven], Paclitaxel injection - Breast Cancer Female, Neoplasm, Breast | Phase 4 | Unknown | Institut fuer Frauengesundheit | 82 | 2021-03-11 | 2023-04-18 |
| Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy Axillary lymph node dissection, Axillary radiotherapy, Breast or chest wall radiotherapy - Breast Cancer, Sentinel Lymph Node | Not applicable | Recruiting | University Hospitals of Derby and Burton NHS Foundation Trust | 1900 | 2021-02-26 | 2026-03-30 |
| Cooling Cap Trial to Prevent Permanent Chemotherapy-induced Alopecia in Breast Cancer Patients Scalp cooling system 2 - Neoplasm, Breast | Not applicable | Completed | Samsung Medical Center | 170 | 2020-12-23 | 2024-11-05 |
| Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer Pyrotinib, Trastuzumab, Docetaxel - Breast Cancer, Neoplasm, Breast | Not applicable | Unknown | Zhejiang Cancer Hospital | 100 | 2019-08-01 | 2019-08-13 |
| 9-ING-41 in Patients With Advanced Cancers 9-ING-41, Gemcitabine - 21 day cycle, Doxorubicin. - Cancer, Pancreatic Cancer | Phase 2 | Active not recruiting | Actuate Therapeutics Inc. | 350 | 2019-01-04 | 2026-04-03 |
| To Accurately Assess Lymph Node Response to NACT by Wire Localization of Clip-marked Lymph Nodes wire localization - Neoplasm, Breast, Neoadjuvant Chemotherapy | Not applicable | Unknown | Peking University | 230 | 2018-10-20 | 2021-11-29 |
| DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein DS-8201a - Adenocarcinoma, Gastric, Neoplasm, Breast | Phase 1 | Completed | Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company | 12 | 2018-04-02 | 2022-11-03 |
Breast Neoplasms (14) · Breast Diseases (2) · Cardiotoxicity (2) · Colorectal Neoplasms (2) · Heart Failure (2) · Neoplasms (2) · Adenocarcinoma (1) · Bone Neoplasms (1) · Chronic Pain (1) · Genetic Diseases, Inborn (1) · Glioma (1) · Hereditary Sensory and Autonomic Neuropathies (1) · Kidney Neoplasms (1) · Leukemia-Lymphoma, Adult T-Cell (1) · Lung Neoplasms (1)
Neoplasms by Site (14) · Skin Diseases (14) · Skin and Connective Tissue Diseases (14) · Breast Diseases (12) · Neoplasms (12) · Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4) · Digestive System Diseases (3) · Digestive System Neoplasms (3) · Gastrointestinal Diseases (3) · Gastrointestinal Neoplasms (3) · Cardiovascular Diseases (2) · Chemically-Induced Disorders (2) · Colonic Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)
Carboplatin (2) · Paclitaxel (2) · 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione (1) · Albumin-Bound Paclitaxel (1) · Alpelisib (1) · Decision Support Techniques (1) · Docetaxel (1) · Doxorubicin (1) · Echocardiography (1) · Environmental Biomarkers (1) · Fulvestrant (1) · Gemcitabine (1) · Gene Expression (1) · Irinotecan (1) · Lomustine (1)
Actuate Therapeutics Inc. (1) · Baylor College of Medicine (1) · Borstkanker Onderzoek Groep (1) · Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company (1) · Institut fuer Frauengesundheit (1) · Karolinska Institutet (1) · Peking University (1) · Samsung Medical Center (1) · Silesian Centre for Heart Diseases (1) · Taipei City Hospital (1) · Universiteit Antwerpen (1) · University Hospitals of Derby and Burton NHS Foundation Trust (1) · University Medical Center Groningen (1) · Zhejiang Cancer Hospital (1)
Netherlands (3) · Belgium (2) · China (2) · Taiwan (2) · United States (2) · Canada (1) · France (1) · Germany (1) · Ireland (1) · Poland (1) · Portugal (1) · South Korea (1) · Spain (1) · Sweden (1) · United Kingdom (1)
Amit Goyal, MS, MD, FRCS (1) · An De Groef, Prof. (1) · Chung-Hua Hsu, MD. PhD (1) · Ding Xiaowen, DR. (1) · Inge I.R. Konings, MD PhD (1) · Jin Seok Ahn, MD, PhD (1) · Kaisa Fritzell, PhD (1) · Mateusz Tajstra (1) · Mira Meeus, Prof. (1) · Natalie Chen, MD (1) · Peter A Fasching, MD, Prof. (1) · Tao Ouyang, Dr. (1)
PMID 24327518, PMID 27424289, PMID 28053024, PMID 28672195, PMID 29383130, PMID 29846250, PMID 30405781, PMID 30975030, PMID 31101621, PMID 31401903, PMID 31533931, PMID 31831767, PMID 31882719, PMID 31894292, PMID 35815408, PMID 37302393, PMID 37449716, PMID 38843479, PMID 39725764, PMID 40285812, PMID 41981308